产品名称
抗囊泡单胺转运蛋白2抗体, Chemicon®, from rabbit
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
rat
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... SLC18A2(6571)
Preparation Note
自收到之日起在-20°C可稳定保存1年。避免反复冻融。为了最大程度地回收产品，在融化后和取下盖子之前，将原始小瓶进行离心。
Analysis Note
对照
大鼠脑组织
大鼠脑组织
Application
抗囊泡单胺转运蛋白2抗体是一种抗囊泡单胺转运蛋白2的抗体，用于ELISA、IH & WB。
研究子类别
离子通道 & 转运体
离子通道 & 转运体
研究类别
神经科学
神经科学
蛋白质印迹：1-10 μg/mL（化学发光技术）
免疫组织化学：1-20 μg/mL，在多聚甲醛固定切片上。
ELISA：0.5-1.0 μg/mL（1 μg/mL VMAT1肽（目录编号AG251）/孔）
最佳工作稀释度必须由最终用户进行确定。
免疫组织化学：1-20 μg/mL，在多聚甲醛固定切片上。
ELISA：0.5-1.0 μg/mL（1 μg/mL VMAT1肽（目录编号AG251）/孔）
最佳工作稀释度必须由最终用户进行确定。
Biochem/physiol Actions
可识别囊泡单胺转运蛋白2（VMAT2）。针对C-末端VMAT2肽制备的抗体在用VMAT2转染的CHO的核后上清液中检测到约55 kDa的主要条带，而在野生型细胞中未检测到（Peter et al.1995；Nirenberg et al.1995）。还检测到一些其他条带，包括较高和较低的分子量，并且不受蛋白酶抑制剂的影响。较高的分子量带可代表糖基化的VMAT2（Peter et al. 1995; Nirenberg et al. 1995, Liu et al. 1994）。VMAT2已定位于肾上腺嗜铬细胞、交感神经腱鞘囊肿细胞、胃的肠嗜铬样细胞和CNS中（Peter et al. 1995; Nirenberg et al. 1995; Nirenberg et al. 1996）。 由于大鼠和人VMAT2之间92%的同源性，可能识别人。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
General description
55 kDa
Immunogen
来自大鼠VMAT2的13个氨基酸的C-末端肽序列（Liu et al.1992）。预计该肽是细胞质的。
Other Notes
浓度：请参考批次特异性浓缩物的检验报告。
Physical form
免疫亲和纯化
含0.1% BSA的PBS溶液。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Ioannis Kourtesis et al.
ASN neuro, 7(5) (2015-10-31)
The spontaneously hypertensive rat (SHR) replicates many clinically relevant features of human essential hypertension and also exhibits behavioral symptoms of attention-deficit/hyperactivity disorder and dementia. The SHR phenotype is highly complex and cannot be explained by a single genetic or physiological
Rodolfo Gonzalez et al.
Cell transplantation, 24(4), 681-690 (2015-04-04)
Recent studies indicate that human pluripotent stem cell (PSC)-based therapies hold great promise in Parkinson's disease (PD). Clinical studies have shown that grafted fetal neural tissue can achieve considerable biochemical and clinical improvements in PD. However, the source of fetal
Jeffery C Sobieraj et al.
Brain structure & function, 221(1), 261-276 (2014-10-03)
Exercise (physical activity) has been proposed as a treatment for drug addiction. In rodents, voluntary wheel running reduces cocaine and nicotine seeking during extinction, and reinstatement of cocaine seeking triggered by drug-cues. The purpose of this study was to examine
Francesco Della Valle et al.
Stem cell reports, 14(1), 60-74 (2020-01-07)
In mammals, LINE-1 (L1) retrotransposons constitute between 15% and 20% of the genome. Although only a few copies have retained the ability to retrotranspose, evidence in brain and differentiating pluripotent cells indicates that L1 retrotransposition occurs and creates mosaics in
Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies.
Tong, J; Boileau, I; Furukawa, Y; Chang, LJ; Wilson, AA; Houle, S; Kish, SJ
Journal of Cerebral Blood Flow and Metabolism null
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持